Neurogen Corporation (NRGN) Announces Second Quarter 2009 Financial Results
8/17/2009 9:25:09 AM
BRANFORD, Conn.--(BUSINESS WIRE)--Neurogen Corporation (NASDAQ: NRGN), a drug development company focused on improved drugs for psychiatric and neurological disorders, today announced financial results for the quarter ended June 30, 2009.
|